Cargando…

Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis

BACKGROUND: Pulmonary infection is the main cause of death in cystic fibrosis (CF). Aspergillus fumigatus (AF) and Pseudomonas aeruginosa (PA) are the most prevalent fungal and bacterial pathogens isolated from the CF airway, respectively. Our aim was to determine the effect of different colonisatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Reece, Emma, Segurado, Ricardo, Jackson, Abaigeal, McClean, Siobhán, Renwick, Julie, Greally, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401475/
https://www.ncbi.nlm.nih.gov/pubmed/28431569
http://dx.doi.org/10.1186/s12890-017-0416-4
_version_ 1783231057441587200
author Reece, Emma
Segurado, Ricardo
Jackson, Abaigeal
McClean, Siobhán
Renwick, Julie
Greally, Peter
author_facet Reece, Emma
Segurado, Ricardo
Jackson, Abaigeal
McClean, Siobhán
Renwick, Julie
Greally, Peter
author_sort Reece, Emma
collection PubMed
description BACKGROUND: Pulmonary infection is the main cause of death in cystic fibrosis (CF). Aspergillus fumigatus (AF) and Pseudomonas aeruginosa (PA) are the most prevalent fungal and bacterial pathogens isolated from the CF airway, respectively. Our aim was to determine the effect of different colonisation profiles of AF and PA on the clinical status of patients with CF. METHODS: A retrospective analysis of data from the Cystic Fibrosis Registry of Ireland from 2013 was performed to determine the effect of intermittent and persistent colonisation with AF or PA or co-colonisation with both microorganisms on clinical outcome measures in patients with CF. Key outcomes measured included forced expiratory volume in one second (FEV(1)), number of hospitalisations, respiratory exacerbations and antimicrobials prescribed, and complications of CF, including CF related diabetes (CFRD) and allergic bronchopulmonary aspergillosis (ABPA). RESULTS: The prevalence of AF and PA colonisation were 11% (5% persistent, 6% intermittent) and 31% (19% persistent, 12% intermittent) in the Irish CF population, respectively. Co-colonisation with both pathogens was associated with a 13.8% reduction in FEV(1) (p = 0.016), higher levels of exacerbations (p = 0.042), hospitalisations (p = 0.023) and antimicrobial usage (p = 0.014) compared to non-colonised patients and these clinical outcomes were comparable to those persistently colonised with PA. Intermittent and persistent AF colonisation were not associated with poorer clinical outcomes or ABPA. Patients with persistent PA had a higher prevalence of CFRD diagnosis (p = 0.012). CONCLUSIONS: CF patients co-colonised with AF and PA had poor clinical outcomes comparable to patients persistently colonised with PA, emphasising the clinical significance of co-colonisation with these microorganisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12890-017-0416-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5401475
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54014752017-04-24 Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis Reece, Emma Segurado, Ricardo Jackson, Abaigeal McClean, Siobhán Renwick, Julie Greally, Peter BMC Pulm Med Research Article BACKGROUND: Pulmonary infection is the main cause of death in cystic fibrosis (CF). Aspergillus fumigatus (AF) and Pseudomonas aeruginosa (PA) are the most prevalent fungal and bacterial pathogens isolated from the CF airway, respectively. Our aim was to determine the effect of different colonisation profiles of AF and PA on the clinical status of patients with CF. METHODS: A retrospective analysis of data from the Cystic Fibrosis Registry of Ireland from 2013 was performed to determine the effect of intermittent and persistent colonisation with AF or PA or co-colonisation with both microorganisms on clinical outcome measures in patients with CF. Key outcomes measured included forced expiratory volume in one second (FEV(1)), number of hospitalisations, respiratory exacerbations and antimicrobials prescribed, and complications of CF, including CF related diabetes (CFRD) and allergic bronchopulmonary aspergillosis (ABPA). RESULTS: The prevalence of AF and PA colonisation were 11% (5% persistent, 6% intermittent) and 31% (19% persistent, 12% intermittent) in the Irish CF population, respectively. Co-colonisation with both pathogens was associated with a 13.8% reduction in FEV(1) (p = 0.016), higher levels of exacerbations (p = 0.042), hospitalisations (p = 0.023) and antimicrobial usage (p = 0.014) compared to non-colonised patients and these clinical outcomes were comparable to those persistently colonised with PA. Intermittent and persistent AF colonisation were not associated with poorer clinical outcomes or ABPA. Patients with persistent PA had a higher prevalence of CFRD diagnosis (p = 0.012). CONCLUSIONS: CF patients co-colonised with AF and PA had poor clinical outcomes comparable to patients persistently colonised with PA, emphasising the clinical significance of co-colonisation with these microorganisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12890-017-0416-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-21 /pmc/articles/PMC5401475/ /pubmed/28431569 http://dx.doi.org/10.1186/s12890-017-0416-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Reece, Emma
Segurado, Ricardo
Jackson, Abaigeal
McClean, Siobhán
Renwick, Julie
Greally, Peter
Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
title Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
title_full Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
title_fullStr Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
title_full_unstemmed Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
title_short Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
title_sort co-colonisation with aspergillus fumigatus and pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an irish registry analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401475/
https://www.ncbi.nlm.nih.gov/pubmed/28431569
http://dx.doi.org/10.1186/s12890-017-0416-4
work_keys_str_mv AT reeceemma cocolonisationwithaspergillusfumigatusandpseudomonasaeruginosaisassociatedwithpoorerhealthincysticfibrosispatientsanirishregistryanalysis
AT seguradoricardo cocolonisationwithaspergillusfumigatusandpseudomonasaeruginosaisassociatedwithpoorerhealthincysticfibrosispatientsanirishregistryanalysis
AT jacksonabaigeal cocolonisationwithaspergillusfumigatusandpseudomonasaeruginosaisassociatedwithpoorerhealthincysticfibrosispatientsanirishregistryanalysis
AT mccleansiobhan cocolonisationwithaspergillusfumigatusandpseudomonasaeruginosaisassociatedwithpoorerhealthincysticfibrosispatientsanirishregistryanalysis
AT renwickjulie cocolonisationwithaspergillusfumigatusandpseudomonasaeruginosaisassociatedwithpoorerhealthincysticfibrosispatientsanirishregistryanalysis
AT greallypeter cocolonisationwithaspergillusfumigatusandpseudomonasaeruginosaisassociatedwithpoorerhealthincysticfibrosispatientsanirishregistryanalysis